Showing results (281-290 of 414) with videos related to
Sort By:
Pageof 42
CA: a Cancer Journal for Clinicians|March 1, 1994
Clinical highlights from the National Cancer Data Base: 1994G D Steele, R T Osteen, D P Winchester, et al.The Journal of Urology|February 1, 1975
Ectopic production of erythropoietin in Wilms tumor patients in relation to clinical stage and disease activityG P Murphy, E A Mirand, L F Sinks, et al.Urology|December 1, 1996
Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigenT O Morgan, D G McLeod, E S Leifer, et al.The Journal of Urology|January 1, 1982
Treatment of testicular tumors arising in patients with previous inguinal and/or scrotal surgeryV J Lanteri, M Choudhury, J E Pontes, et al.Annals of the New York Academy of Sciences|January 1, 1982
Immunochemical characterization of prostatic acid phosphatase with monoclonal antibodiesC L Lee, C Y Li, Y H Jou, et al.Annals of the New York Academy of Sciences|January 1, 1982
Prostate-specific acid phosphatase versus acid phosphatase in monitoring patients with prostate cancerC S Killian, F P Vargas, N H Slack, et al.Cancer|December 24, 1997
The National Cancer Data Base report on recent hospital cancer program progress toward complete American Joint Committee on Cancer/TNM stagingI D Fleming, J L Phillips, H R Menck, et al.Cancer Research|March 8, 2000
Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trialP A Lodge, L A Jones, R A Bader, et al.Cancer|December 11, 1999
American Joint Committee on Cancer prognostic factors consensus conferenceJ W Yarbro, D L Page, L P Fielding, et al.Journal of Steroid Biochemistry|May 1, 1985
A comparison of estrogen and androgen receptor levels in human prostatic tissue from patients with non-metastatic and metastatic carcinoma and benign prostatic hyperplasiaR Y Kirdani, L J Emrich, E J Pontes, et al.Pageof 42